October 2007 Report to Steering Committee
Report to Steering Committee | Pre-Meeting Contributions | Other Links
SESSION I: Definitions and Qualitative Descriptions of Fatigue
Andrea Barsevick
- Meeting Format and Preliminaries
- Conceptual Definitions of Fatigue
- Core Outcome Domains For Chronic Pain Clinical Trials
David Cella: Cancer Fatigue Dimensions?
Recap: Bullet points from SESSION I
SESSION II: Conceptualizing Fatigue in Cancer
Kelly Grotzinger, Marlene Frost, and Jane Scott: Conceptualizing Fatigue
Recap: Bullet points from SESSION II
SESSION III: Current Status of Clinical Trials
Ann O'Mara: Overview of NCI-Supported Fatigue Trials
Elizabeth Piault: In Their Own Words: Quotes from Cancer Patients About Fatigue
Recap: Qualitative Research draft report
SESSION IV: Target Product Claims
Don Manning:
SESSION V: Measurement of Fatigue in Clinical Trials
Bryce Reeve: Measurement of Fatigue in Cancer Clinical Trials
Mark Jensen: Validity of Fatigue Recall Ratings
Charlie Cleeland: Longitudinal Assessment of Cancer-Related Fatigue: When to use it? What does it add?
Maria Sgambati: Fatigue Measurement in NCI-Sponsored Clinical Trials
Recap: Bullet points from SESSION V
SESSION VI: Study Design
Shelley Wang: Determinants and Confounding Issues for CRF
Jeff Sloan: EORTC QLQ-FA-R15 (Version Phase II)
Don Manning:
SESSION VII: Review of the Consensus and Next Steps
Jeff Sloan: Achievements/Consensus